Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Male hormonal contraceptives.

J K Amory1

  • 1Center for Research in Reproduction and Contraception, Department of Medicine, University of Washington, Seattle, WA 98195, USA. jamory@u.washington.edu

Minerva Ginecologica
|June 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men.

Andrology·2019
Same author

Isotretinoin administration improves sperm production in men with infertility from oligoasthenozoospermia: a pilot study.

Andrology·2017
Same author

Comparison of the single dose pharmacokinetics, pharmacodynamics, and safety of two novel oral formulations of dimethandrolone undecanoate (DMAU): a potential oral, male contraceptive.

Andrology·2016
Same author

Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gels.

Andrology·2013
Same author

Intratesticular 13-cis retinoic acid is lower in men with abnormal semen analyses: a pilot study.

Andrology·2013
Same author

Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazole.

The Journal of clinical endocrinology and metabolism·2013

Developing male hormonal contraceptives using exogenous testosterone (T) shows promise. Combined with progestogens, these methods are safe, effective, and reversible, with ongoing research for optimal male birth control.

Area of Science:

  • Reproductive Endocrinology
  • Contraceptive Development
  • Male Reproductive Health

Background:

  • Male hormonal contraception is being developed using exogenous testosterone (T).
  • Testosterone suppresses pituitary gonadotropins, inhibiting spermatogenesis.
  • Existing methods are safe, effective, and reversible but don't suppress sperm production in all men.

Purpose of the Study:

  • To review the development and efficacy of male hormonal contraceptives.
  • To explore combination therapies for enhanced contraceptive effectiveness.
  • To assess the safety and reversibility of novel male contraceptive approaches.

Main Methods:

  • Administration of exogenous testosterone (T) to suppress gonadotropins.
  • Combination therapy with T and progestogens or GnRH antagonists.

Related Experiment Videos

  • Evaluation of sperm counts, hormone levels, and side effects in clinical trials.

    • Main Results:

    • Exogenous testosterone effectively reduces sperm counts in most men within 2-3 months.
    • Combination therapies with T and progestogens achieve near-complete spermatogenesis suppression in 80-90% of men.
    • Sperm counts normalize upon discontinuation of treatment, indicating reversibility.

    Conclusions:

    • Male hormonal contraception using testosterone is safe, effective, and reversible.
    • Combination therapies offer improved contraceptive efficacy.
    • Newer long-acting formulations show significant promise for future male birth control options.